Inside the life of a rural hospital.
Health Care
That Wildly Expensive New Alzheimer’s Drug Needs Serious Testing
Why Biogen’s medication, aducanumab, should get studied through an important part of the Affordable Care Act, the Patient Centers Outcomes Research Institute.
The All-Payer Pricing Alternative
Public option proponents face huge political hurdles; there is another way to achieve many of the same goals.
As FDA Readies Menthol Cigarette Ban, What’s Next?
Public health agencies need to make menthol smokers, Black and white, aware of safer alternatives. Anything less isn’t social justice.
Biden’s Pivot on Drug Price Controls
The president abandons the long-held view that innovation requires high prices.
How Mistreating Nursing Home Staff Helped Spread Covid-19
Poorly paid direct care workers with multiple jobs who can’t afford sick leave spread the pandemic to the most vulnerable. Here’s how we can do better.
My Johnson & Johnson Vaccination Was Canceled. How Mad Should I Be?
Part of me gets the need to balance risk. Part of me wants to scream.
The FDA Cut Off Covid Vaccine Testing. That Was a Really Bad Idea.
The shots are saving lives, but we don’t know their long-term effects thanks to an agency that often answers to industry instead of the public.
The Nation’s Capital Can’t Vaccinate Its Residents
Every metric puts D.C. one or two notches up from dead last. Even Mississippi does it better. Why isn’t this a bigger story?
Obamacare and Its Enemies
An insightful new history of the Affordable Care Act—and the fight to save it—points to a difficult road ahead for insuring Americans.
